These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 23569237)

  • 1. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells.
    Wei Y; Jiang Y; Zou F; Liu Y; Wang S; Xu N; Xu W; Cui C; Xing Y; Liu Y; Cao B; Liu C; Wu G; Ao H; Zhang X; Jiang J
    Proc Natl Acad Sci U S A; 2013 Apr; 110(17):6829-34. PubMed ID: 23569237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.
    Soeda A; Park M; Lee D; Mintz A; Androutsellis-Theotokis A; McKay RD; Engh J; Iwama T; Kunisada T; Kassam AB; Pollack IF; Park DM
    Oncogene; 2009 Nov; 28(45):3949-59. PubMed ID: 19718046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Girdin maintains the stemness of glioblastoma stem cells.
    Natsume A; Kato T; Kinjo S; Enomoto A; Toda H; Shimato S; Ohka F; Motomura K; Kondo Y; Miyata T; Takahashi M; Wakabayashi T
    Oncogene; 2012 May; 31(22):2715-24. PubMed ID: 22020337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
    Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
    Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
    Ping YF; Yao XH; Jiang JY; Zhao LT; Yu SC; Jiang T; Lin MC; Chen JH; Wang B; Zhang R; Cui YH; Qian C; Wang Jm; Bian XW
    J Pathol; 2011 Jul; 224(3):344-54. PubMed ID: 21618540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic regulation of CD133/PROM1 expression in glioma stem cells by Sp1/myc and promoter methylation.
    Gopisetty G; Xu J; Sampath D; Colman H; Puduvalli VK
    Oncogene; 2013 Jun; 32(26):3119-29. PubMed ID: 22945648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation.
    Shimozato O; Waraya M; Nakashima K; Souda H; Takiguchi N; Yamamoto H; Takenobu H; Uehara H; Ikeda E; Matsushita S; Kubo N; Nakagawara A; Ozaki T; Kamijo T
    Oncogene; 2015 Apr; 34(15):1949-60. PubMed ID: 24882578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
    Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
    PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
    Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
    Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine promotes the self-renewal and immune escape of CD133+ thyroid cancer cells through activation of CD133-Akt pathway.
    Wang Z; Liu W; Wang C; Li Y; Ai Z
    Cancer Lett; 2020 Feb; 471():116-124. PubMed ID: 31830559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Numb regulates glioma stem cell fate and growth by altering epidermal growth factor receptor and Skp1-Cullin-F-box ubiquitin ligase activity.
    Jiang X; Xing H; Kim TM; Jung Y; Huang W; Yang HW; Song S; Park PJ; Carroll RS; Johnson MD
    Stem Cells; 2012 Jul; 30(7):1313-26. PubMed ID: 22553175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CD133 enhances chemoresistance to 5-fluorouracil by activating the PI3K/Akt/p70S6K pathway in gastric cancer cells.
    Zhu Y; Yu J; Wang S; Lu R; Wu J; Jiang B
    Oncol Rep; 2014 Dec; 32(6):2437-44. PubMed ID: 25230779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PTEN status is related to cell proliferation and self-renewal independent of CD133 phenotype in the glioma-initiating cells.
    Cheng RB; Ma RJ; Wang ZK; Yang SJ; Lin XZ; Rong H; Ma Y
    Mol Cell Biochem; 2011 Mar; 349(1-2):149-57. PubMed ID: 21110069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro.
    Xi G; Hayes E; Lewis R; Ichi S; Mania-Farnell B; Shim K; Takao T; Allender E; Mayanil CS; Tomita T
    Oncogene; 2016 Jan; 35(2):241-50. PubMed ID: 25823028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer.
    Chen YS; Wu MJ; Huang CY; Lin SC; Chuang TH; Yu CC; Lo JF
    PLoS One; 2011; 6(11):e28053. PubMed ID: 22140506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.
    Lai CY; Schwartz BE; Hsu MY
    Cancer Res; 2012 Oct; 72(19):5111-8. PubMed ID: 22865455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist.
    Sarvi S; Mackinnon AC; Avlonitis N; Bradley M; Rintoul RC; Rassl DM; Wang W; Forbes SJ; Gregory CD; Sethi T
    Cancer Res; 2014 Mar; 74(5):1554-65. PubMed ID: 24436149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.
    Tabu K; Kimura T; Sasai K; Wang L; Bizen N; Nishihara H; Taga T; Tanaka S
    Mol Cancer; 2010 Feb; 9():39. PubMed ID: 20167130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.
    Ma S; Tang KH; Chan YP; Lee TK; Kwan PS; Castilho A; Ng I; Man K; Wong N; To KF; Zheng BJ; Lai PB; Lo CM; Chan KW; Guan XY
    Cell Stem Cell; 2010 Dec; 7(6):694-707. PubMed ID: 21112564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.